← Deal Flow

CTIBIOTECH USA

Deep
1Rounds
0Articles
Generating profile summary — check back in a moment.

Highlights

Total Raised
1 rounds
Latest Round
$27
May 10, 2026
Stage
deep-tech
Employees
Headquarters
News Coverage
Talent Signals
SEC Filings

Funding History

$27
2026
Strategic
SEC Form D   Editorial
May 10, 2026
$27 millionStrategic · Editorial

<cite index="11-3,11-4">CTIBIOTECH, a pioneering 3D bioprinting organization and global leader in human tissue bioprinting, announced the launch of its North American subsidiary to provide proprietary human cell and tissue bioassays and New Approach Methods to North American pharmaceutical and biomedical markets.</cite>

Similar Companies 6